Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

Ethnicity and antipsychotic response.

Frackiewicz EJ, Sramek JJ, Herrera JM, Kurtz NM, Cutler NR.

Ann Pharmacother. 1997 Nov;31(11):1360-9. Review.

PMID:
9391692
2.

Pharmacogenetics of antipsychotic treatment: lessons learned from clozapine.

Masellis M, Basile VS, Ozdemir V, Meltzer HY, Macciardi FM, Kennedy JL.

Biol Psychiatry. 2000 Feb 1;47(3):252-66. Review.

PMID:
10682223
3.

Pharmacogenetics of antipsychotic treatment in schizophrenia.

Pouget JG, Müller DJ.

Methods Mol Biol. 2014;1175:557-87. doi: 10.1007/978-1-4939-0956-8_14. Review.

PMID:
25150876
4.

Atypical antipsychotics for psychosis in adolescents.

Kumar A, Datta SS, Wright SD, Furtado VA, Russell PS.

Cochrane Database Syst Rev. 2013 Oct 15;(10):CD009582. doi: 10.1002/14651858.CD009582.pub2. Review.

PMID:
24129841
5.

Pharmacogenetic of response efficacy to antipsychotics in schizophrenia: pharmacodynamic aspects. Review and implications for clinical research.

Blanc O, Brousse G, Meary A, Leboyer M, Llorca PM.

Fundam Clin Pharmacol. 2010 Apr;24(2):139-60. doi: 10.1111/j.1472-8206.2009.00751.x. Epub 2009 Aug 21. Review.

PMID:
19702693
6.

Benzodiazepines for schizophrenia.

Volz A, Khorsand V, Gillies D, Leucht S.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD006391. Review. Update in: Cochrane Database Syst Rev. 2012;11:CD006391.

PMID:
17253592
7.
8.

Pharmacogenetics and psychopharmacotherapy.

Poolsup N, Li Wan Po A, Knight TL.

J Clin Pharm Ther. 2000 Jun;25(3):197-220. Review.

PMID:
10886465
9.

Benzodiazepines for schizophrenia.

Dold M, Li C, Tardy M, Khorsand V, Gillies D, Leucht S.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD006391. doi: 10.1002/14651858.CD006391.pub2. Review.

PMID:
23152236
10.

Perphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia.

Tardy M, Huhn M, Engel RR, Leucht S.

Cochrane Database Syst Rev. 2014 Oct 7;(10):CD009369. doi: 10.1002/14651858.CD009369.pub2. Review.

PMID:
25290157
11.

Gender differences in depression and antidepressant pharmacokinetics and adverse events.

Frackiewicz EJ, Sramek JJ, Cutler NR.

Ann Pharmacother. 2000 Jan;34(1):80-8. Review.

PMID:
10669189
12.

Pharmacogenetics and schizophrenia.

Foster A, Miller DD, Buckley P.

Clin Lab Med. 2010 Dec;30(4):975-93. doi: 10.1016/j.cll.2010.07.010. Review.

PMID:
20832661
13.

[Pharmacogenetics of antipsychotics in schizophrenia].

Méary A.

Therapie. 2008 May-Jun;63(3):243-6. doi: 10.2515/therapie:2008033. Epub 2008 Aug 23. Review. French.

PMID:
18718213
14.

Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research.

Arranz MJ, de Leon J.

Mol Psychiatry. 2007 Aug;12(8):707-47. Epub 2007 Jun 5. Review.

PMID:
17549063
15.

Pharmacogenetics of antipsychoatics.

Ozaki N.

Nagoya J Med Sci. 2004 May;67(1-2):1-7. Review.

PMID:
15279062
16.

The cost effectiveness of long-acting/extended-release antipsychotics for the treatment of schizophrenia: a systematic review of economic evaluations.

Achilla E, McCrone P.

Appl Health Econ Health Policy. 2013 Apr;11(2):95-106. doi: 10.1007/s40258-013-0016-2. Review.

PMID:
23494934
17.

Blood glucose and schizophrenia: a systematic review of prospective randomized clinical trials.

Bushe CJ, Leonard BE.

J Clin Psychiatry. 2007 Nov;68(11):1682-90. Review.

PMID:
18052561
18.

Personalized antipsychotic treatment: the adverse effects perspectives.

Plesnicar BK.

Psychiatr Danub. 2010 Jun;22(2):329-34. Review.

19.

Pharmacogenetics of clozapine treatment response and side-effects in schizophrenia: an update.

Sriretnakumar V, Huang E, Müller DJ.

Expert Opin Drug Metab Toxicol. 2015;11(11):1709-31. doi: 10.1517/17425255.2015.1075003. Epub 2015 Sep 12. Review.

PMID:
26364648
20.

Influence of race or ethnicity on pharmacokinetics of drugs.

Johnson JA.

J Pharm Sci. 1997 Dec;86(12):1328-33. Review.

PMID:
9423140

Supplemental Content

Support Center